Functional polymorphisms in the promoter region of macrophage migration inhibitory factor and chronic gastritis

International Journal of Molecular Medicine

Volumn 20, Issue 4, 2007, Pages 539-544

  Arisawa, Tomiyasu ^a   Tahara, Tomomitsu ^a   Shibata, Tomoyuki ^a   Nagasaka, Mitsuo ^a   Nakamura, Masakatsu ^a   Kamiya, Yoshio ^a   Fujita, Hiroshi ^a   Nakamura, Masahiko ^a   Yoshioka, Daisuke ^a   Arima, Yuko ^a   Okubo, Masaaki ^a   Hirata, Ichiro ^a   Nakano, Hiroshi ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chronic gastritis; Helicobacter pylori; Macrophage migration inhibitory factor; Promoter polymorphism

Indexed keywords

MACROPHAGE MIGRATION INHIBITION FACTOR;

ARTICLE; ATROPHY; CELL MOTION; CHRONIC DISEASE; FEMALE; GASTRITIS; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HUMAN; INFLAMMATION; MALE; MIDDLE AGED; NUCLEOTIDE REPEAT; PATHOLOGY; PROMOTER REGION; RISK FACTOR; SINGLE STRAND CONFORMATION POLYMORPHISM; STOMACH MUCOSA;

ATROPHY; CELL MOVEMENT; CHRONIC DISEASE; FEMALE; GASTRIC MUCOSA; GASTRITIS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFLAMMATION; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROMOTER REGIONS (GENETICS); REPETITIVE SEQUENCES, NUCLEIC ACID; RISK FACTORS;

EID: 38449085332     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.20.4.539     Document Type: Article

References (39)

1. Donnelly SC and Bucala R: Macrophage migration inhibitory factor: a regulator of glucocorticoid activity with a critical role in inflammatory disease. Mol Med Today 3: 502-507, 1999.
2. Lue H, Kleemann R, Calandra T, Roger T and Bernhagen J: Macrophage migration inhibitory factor (MIF): Mechanisms of action and role in disease. Microb Infect 4: 449-460, 2002.
3. Lan HY, Yang N, Nikolic-Paterson DJ, et al: Expression of macrophage migration inhibitory factor in human glomerulonephritis. Kidney Int 57: 499-509, 2000.
4. de Jong YP, Abadia-Molina AC, Satoskar AR, et al: Development of chronic colitis is dependent on the cytokine MIF. Nat Immunol 2: 1061-1066, 2001.
5. Kumagi T, Akbar F, Horiike N and Onji M: Increased serum levels of macrophage migration inhibitory factor in alcoholic liver diseases and their expression in liver tissues. Clin Biochem 34: 189-193, 2001.
6. Calandra T, Echtenacher B, Roy DL, et al: Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat Med 6: 164-170, 2000. (Pubitemid 30082360)
7. Donnelly SC, Haslett C, Reid PT, et al: Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat Med 3: 320-323, 1997.
8. Roger T, David J, Glauser M and Calandra T: MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature 414: 920-924, 2001.
9. Xia HHX, Lam SK, Huang XR, et al: Helicobacter pylori infection is associated with increased expression of macrophage migration inhibitory factor by epithelial cells, T cells and macrophages in gastric mucosa. J Infect Dis 190: 293-302, 2004.
10. Donn R, Alourfi Z, De Benedetti F, et al: British Paediatric Rheumatology Study Group. Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis. Arthritis Rheum 46: 2402-2409, 2002.
11. Amoli MM, Donn RP, Thomson W, et al: Macrophage migration inhibitory factor gene polymorphism is associated with sarcoidosis in biopsy proven erythema nodosum. J Rheumatol 29: 1671-1673, 2002.
12. Baugh JA, Chitnis S, Donnelly SC, et al: A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis. Genes Immun 3: 170-176, 2002.
13. Dixon MF, Genta RM, Yardley JH and Correa P: Classification and grading of gastritis: the updated Sydney system. Am J Surg Pathol 20: 1161-1181, 1996.
14. Arisawa T, Tahara T, Shibata T, et al: The relationship between Helicobacter pylori infection and promoter polymorphism of the Nrf2 gene in chronic gastritis. Int J Mol Med 19: 143-148, 2007.
15. Arisawa T, Tahara T, Shibata T, et al: A polymorphism of microRNA 27a genome region is associated with the development of gastric mucosal atrophy in Japanese male subjects. Dig Dis Sci 52: 1691-1697, 2007. (Pubitemid 46870565)
16. Correa P: Human gastric carcinogenesis: a multistep and multifactorial process. First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 52: 6735-6740, 1992.
17. Arisawa T, Tahara T, Shibata T, Nagasaka M, Nakamura M, Kamiya Y, Fujita H, Hasegawa S, Nakamura M, Takagi T, Hirata I and Nakano H: A F240S polymorphism of protease-activated receptor 2 (PAR2) is not detected in Japanese population with gastro-esophageal symptoms. J Clin Biochem Nutr 39: 98-101, 2006.
18. Tahara T, Arisawa T, Shibata T, Hirata I and Nakano H: Absence of common polymorphisms of Toll like receptor 4 (TLR4): Asp299Gly, Thr399Ile in patients with gastroduodenal diseases in Japan. J Clin Biochem Nutr 40: 62-65, 2007.
19. Bloom BR and Bennett B: Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 153: 80-82, 1966.
20. David JR: Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci USA 56: 72-77, 1966.
21. Weiser WY, Temple PA, Witek-Giannotti JS, Remold HG, Clark SC and David JR: Molecular cloning of a cDNA encoding a human macrophage migration inhibitory factor. Proc Natl Acad Sci USA 86: 7522-7526, 1989.
22. Leech M, Metz C, Hall P, et al: Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids. Arthritis Rheum 42: 1601-1608, 1999.
23. Bernhagen J, Calandra T and Bucala R: The emerging role of MIF in septic shock and infection. Biotherapy 8: 123-127, 1995. (Pubitemid 26014886)
24. Donnelly SC, Bucala R, Metz CN, et al: Macrophage migration inhibitory factor and acute lung injury. Chest 116: 111S, 1999.
25. Tulic MK, Wale JL, Holt PG and Sly PD: Modification of the inflammatory response to allergen challenge after exposure to bacterial lipopolysaccharide. Am J Respir Cell Mol Biol 22: 604-612, 2000.
26. Gereda JE, Leung DY, Thatayatikom A, et al: Relation between house-dust endotoxin exposure, type-1 T-cell development, and allergen sensitization in infants at high risk of asthma. Lancet 355: 1680-1683, 2000.
27. Huang XR, Chun HCW, Chen YX, et al: Macrophage migration inhibitory factor is an important mediator in the pathogenesis of gastric inflammation in rats. Gastroenterology 121: 619-630, 2001.
28. He XX, Yang J, Ding YW, Liu W, Shen QY and Xia HH: Increased epithelial and serum expression of macrophage migration inhibitory factor (MIF) in gastric cancer: potential role of MIF in gastric carcinogenesis. Gut 55: 797-802, 2006. (Pubitemid 43764549)
29. Bamford KB, Fan X, Crowe SE, et al: Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology 88: 70-74, 1998.
30. Calandra T, Bernhagen J, Mitchell RA and Bucala R: Macrophage is an important and previously unrecognized source of macrophage-migration inhibitory factor. J Exp Med 179: 1895-1902, 1994.
31. Bacher M, Mets CN, Calandra T, et al: An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci USA 93: 7849-7854, 1996. (Pubitemid 26277127)
32. Benigni F, Atsumi T, Calandra T, et al: The proinflammatory mediator macrophage migration inhibitory factor induces glucose catabolism in muscle. J Clin Invest 106: 1291-1300, 2000.
33. Abe R, Peng T, Sailors J, Bucala R and Metz CN: Regulation of the CTL response by macrophage migration inhibitory factor. J Immunol 166: 747-753, 2001. (Pubitemid 32060224)
34. Plant BJ, Gallagher CG, Bucala R, et al: Cystic fibrosis, disease severity, and a macrophage migration inhibitory factor polymorphism. Am J Respir Crit Care Med 172: 1412-1415, 2005.
35. Donn RP, Plant D, Jury F, et al: Macrophage migration inhibitory factor gene polymorphism is associated with psoriasis. J Invest Dermatol 123: 484-487, 2004.
36. Hizawa N, Yamaguchi E, Takahashi D, Nishihara J and Nishimura M: Functional polymorphisms in the promoter region of macrophage migration inhibitory factor and atopy. Am J Respir Crit Care Med 169: 1014-1018, 2004.
37. Kawaguchi H, Haruma K, Komoto K, Yoshihara M, Sumii K and Kajiyama G: Helicobacter pylori infection is the major risk factor for atrophic gastritis. Am J Gastroenterol 91: 959-962, 1996.
38. Kuipers EJ, Uyterlinde AM, Pena AS, et al: Long-term sequelae of Helicobacter pylori gastritis. Lancet 345: 1525-1528, 1995.
39. Sakamoto W, Isomura H, Fujie K, et al: The effect of vitamin K2 on bone metabolism in aged female rats. Osteoporos Int 16: 1604-1610, 2005. (Pubitemid 41790865)